Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fumiaki Sugiura

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Biochemical and Biophysical Research Communications|March 9, 2004
Osteogenic potential of rat mesenchymal stem cells after several passagesFumiaki Sugiura, Hiroshi Kitoh, Naoki Ishiguro
Biochemical and Biophysical Research Communications|February 5, 2003
Chondrogenesis enhanced by overexpression of sox9 gene in mouse bone marrow-derived mesenchymal stem cellsHiroki Tsuchiya, Hiroshi Kitoh, Fumiaki Sugiura, et al.
Anticancer Research|June 13, 2014
Clinical trial of a 7-peptide cocktail vaccine with oral chemotherapy for patients with metastatic colorectal cancerKiyotaka Okuno, Fumiaki Sugiura, Keisuke Inoue, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 25, 2012
[New directions in immunotherapy for malignant solid tumors]Kiyotaka Okuno, Fumiaki Sugiura, Yasushi Sukegawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 27, 2012
[Clinical study of Peptide-cocktail vaccination with tegafur-uracil/leucovorin for advanced colorectal cancer]Fumiaki Sugiura, Keisuke Inoue, Kiyotaka Okuno, et al.
Acta Orthopaedica|April 28, 2007
The effect of recombinant human bone morphogenetic protein-2 on the osteogenic potential of rat mesenchymal stem cells after several passagesHisato Ishikawa, Hiroshi Kitoh, Fumiaki Sugiura, et al.
Modern Rheumatology|October 10, 2006
Anaphylactic reaction to infliximab in two rheumatoid arthritis patients who had previously received infliximab and resumedFumiaki Sugiura, Toshihisa Kojima, Michinari Oba, et al.
Current Pharmaceutical Biotechnology|February 21, 2012
Recent advances in active specific cancer vaccine treatment for colorectal cancerKiyotaka Okuno, Fumiaki Sugiura, Kyogo Itoh, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 29, 2011
[Preliminary study of Peptide vaccine with UFT/LV as adjuvant setting for stage III colorectal cancer]Kiyotaka Okuno, Fumiaki Sugiura, Jin-ichi Hida, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 8, 2014
[Treatment outcome of peptide vaccination for advanced colorectal cancer]Fumiaki Sugiura, Keisuke Inoue, Akihiro Kogita, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Biochemical and Biophysical Research Communications|March 9, 2004
Osteogenic potential of rat mesenchymal stem cells after several passagesFumiaki Sugiura, Hiroshi Kitoh, Naoki Ishiguro
Biochemical and Biophysical Research Communications|February 5, 2003
Chondrogenesis enhanced by overexpression of sox9 gene in mouse bone marrow-derived mesenchymal stem cellsHiroki Tsuchiya, Hiroshi Kitoh, Fumiaki Sugiura, et al.
Anticancer Research|June 13, 2014
Clinical trial of a 7-peptide cocktail vaccine with oral chemotherapy for patients with metastatic colorectal cancerKiyotaka Okuno, Fumiaki Sugiura, Keisuke Inoue, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 25, 2012
[New directions in immunotherapy for malignant solid tumors]Kiyotaka Okuno, Fumiaki Sugiura, Yasushi Sukegawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 27, 2012
[Clinical study of Peptide-cocktail vaccination with tegafur-uracil/leucovorin for advanced colorectal cancer]Fumiaki Sugiura, Keisuke Inoue, Kiyotaka Okuno, et al.
Acta Orthopaedica|April 28, 2007
The effect of recombinant human bone morphogenetic protein-2 on the osteogenic potential of rat mesenchymal stem cells after several passagesHisato Ishikawa, Hiroshi Kitoh, Fumiaki Sugiura, et al.
Modern Rheumatology|October 10, 2006
Anaphylactic reaction to infliximab in two rheumatoid arthritis patients who had previously received infliximab and resumedFumiaki Sugiura, Toshihisa Kojima, Michinari Oba, et al.
Current Pharmaceutical Biotechnology|February 21, 2012
Recent advances in active specific cancer vaccine treatment for colorectal cancerKiyotaka Okuno, Fumiaki Sugiura, Kyogo Itoh, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 29, 2011
[Preliminary study of Peptide vaccine with UFT/LV as adjuvant setting for stage III colorectal cancer]Kiyotaka Okuno, Fumiaki Sugiura, Jin-ichi Hida, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 8, 2014
[Treatment outcome of peptide vaccination for advanced colorectal cancer]Fumiaki Sugiura, Keisuke Inoue, Akihiro Kogita, et al.
Pageof 3